US Airways fights for more loans in Congress battle
US Airways and supporters press Congress to keep the $10 billion emergency airline loan program intact after Sept. 11. They warn that stripping or delaying the loans could push the carrier toward bankruptcy, risking jobs and operations as lawmakers trade off terrorism funding with aviation aid.
MENTIONED IN THIS ARTICLE
Washington
US Airways
Congress
Bush
House
Senate
David Casselveter
Capitol
Senate Committee
East
BREW platform spurs mobile gaming expansion
Cellular phones unlock high tech gaming with BREW platform from Qualcomm fueling a push by major carriers. Verizon leads BREW rollout with Tiger Woods PGA Tour Golf on Sharp devices, offering pay per download or subscription billing while Europe and Asia show strong revenue gains for third party game content.
MENTIONED IN THIS ARTICLE
San Jose
Cali
U.S
BREW
Michael King
Gartner Dataquest
Qualcomm Inc
Carvers
Verizon Wireless
San Diego
Electrom Arts
Sharp Phone
Kyocera
Verizon
Korea
Freetel
KDDI
Japan
Europe
Paul Palmieri
Internet Data Services
Asia
United States
Datamonitor
Panasonic
Jeremy James
Qualcomm
America
Taiwan
Hong Kong
King
Kroger backs new animal welfare guidelines pledge
Kroger said it will support forthcoming FMI animal welfare standards and urge suppliers to adopt them once issued. The Cincinnati retailer touted the joint FMI and NCCR effort with retailers and restaurants, aiming to improve humane treatment of farm animals. PETA praised the move though emphasized audits and supplier enforcement as key issues. Safeway and Albertson’s also said they will adopt the FMI guidelines.
MENTIONED IN THIS ARTICLE
Kroger Co
Food Marketing Institute
FMI
National Council of Chain Restaurants
Kroger
NCCR
Lynn Marmer
Restau
PETA
Bruce Friedrich
Safeway
Albertson’s
Global drug firms circle Bristol-Myers Squibb in potential $62 billion bid
GlaxoSmithKline leads a high-profile takeover bid for Bristol-Myers Squibb amid industry pressure to cut prices and a slower pace of new blockbuster drugs. Analysts note the deal could alter competition, with Novartis and Pfizer peers watching, while concerns about patent cliffs and cost containment shape the allure.
MENTIONED IN THIS ARTICLE
Bristol-Myers Squibb
GlaxoSmithKline PLC
Europe
Pfizer Inc
Los Angeles Times
Glaxos
Peter Boland
David Christopher
Crowell, Weedon and Co
Pharmaceuti
Cal
Datamonitor
GlaxoSmithKline
Steve Gerber
CIBC
World Markets
Glaxo- SmithKline
Bristol-Myers
ImClone Systems Inc
FDA
Merck and Co
Glaxo-SmithKline
Gerber
Cisc World Markets
Bristol- Myers Squibb
Arnie Milstein
Mercer Human Resource Consulting
Pacific Business Group
Milstein
Also Mentioned on This Page
Center For Responsive Politics
Senate Appropriations Committee
Cane Pittman
Jamdat Mobile Inc
Los Angeles
Lorain National Bank
ALNB
Oenmenuer